Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
RESEARCH TOOLSreports
Holding BCLI?
Track your performance easily
Technical Sentiment
Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is -0.34, suggesting Brainstorm Cell Therapeutics is a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 1.54, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1.27, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 2.33, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1.27, making it a Sell.
Brainstorm Cell Therapeutics (BCLI) Pivot Points
Classic
1.11
1.16
1.20
1.25
1.29
1.34
1.38
Fibonacci
1.16
1.19
1.21
1.25
1.28
1.30
1.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Brainstorm Cell Therapeutics (BCLI) Moving Averages
MA5
1.21Buy
1.24Buy
MA10
1.23Buy
1.31Sell
MA20
1.54Sell
1.54Sell
MA50
2.36Sell
2.33Sell
MA100
3.66Sell
3.32Sell
MA200
5.28Sell
4.37Sell
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 1.31, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1.27, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 3.32, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1.27, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $1.27 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 2.36, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $1.27 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 3.66, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $1.27 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 5.28, creating a Sell signal.
Brainstorm Cell Therapeutics (BCLI) Technical Indicators
RSI (14)
27.23
Buy
STOCH (9,6)
31.31
Neutral
STOCHRSI (14)
21.13
Neutral
MACD (12,26)
-0.34
Sell
ADX (14)
33.62
Neutral
Williams %R
-76.67
Buy
CCI (14)
-60.51
Neutral
ATR (14)
0.21
-
Ultimate Oscillator
45.97
Neutral
ROC
-32.62
Sell
Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 27.23, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 33.62, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is -60.51, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is -32.62, creating a Sell signal.
FAQ
Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Sell.
What is BCLI’s RSI (14)?
BCLI’s RSI (14) is 27.23, which suggests BCLI is a Buy.
What is BCLI’s MACD?
BCLI’s MACD is -0.34, which suggests BCLI is a Sell.
What is BCLI’s 5-day moving average?
BCLI’s 5-day moving average is 1.21, which suggests BCLI is a Buy.
What is BCLI’s 20-day moving average?
BCLI 20-day moving average is 1.54, which suggests BCLI is a Sell.
What is BCLI’s 50-day moving average?
BCLI’s 50-day moving average is 2.36, which suggests BCLI is a Sell.
What is BCLI’s 200-day moving average?
BCLI’s 200-day moving average is 5.28, which suggests BCLI is a Sell.
What is BCLI’s Williams % R (14)?
BCLI’s Williams % R (14) is -76.67, which suggests BCLI is a Buy.
What is BCLI’s CCI (14)?
BCLI’s CCI (14) is -60.51, which suggests BCLI is a Neutral.